Form 4: Cryoport Director Sells 11,570 Shares Under 10b5-1 Plan
Insider Transaction Report
Cryoport Director Ramkumar Mandalam reported the sale of 11,570 shares of common stock for approximately $115,550 under a Rule 10b5-1 plan.
Summary
- Ramkumar Mandalam, a Director of Cryoport, Inc. (CYRX), sold 11,570 shares of the company's common stock.
- The transaction occurred on December 10, 2025.
- The shares were sold at a weighted average price of $9.9862 per share, with individual sales ranging from $9.93 to $10.0696.
- The total value of the shares sold is approximately $115,550.
- The sale was executed pursuant to a Rule 10b5-1 trading plan.
- Following this transaction, Mandalam beneficially owns 80,758 shares of Cryoport common stock directly.
Sentiment
Score: 4
Explanation: A director selling shares, even under a 10b5-1 plan, can be perceived as a slightly negative signal by some investors, though it represents a relatively small portion of the director's total holdings and could be for personal financial planning unrelated to company performance.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, which indicates a pre-arranged transaction designed to comply with insider trading laws and is not necessarily a reaction to recent company news.
Negatives
- A director selling shares, even under a pre-arranged plan, can sometimes be interpreted by investors as a signal of reduced confidence in the company's near-term stock performance, although this is not always the case.
Future Outlook
This filing, an insider transaction report, does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction report provides specific details about a director's stock sale and does not offer broader industry context or trends.
Stakeholder Impact
- Shareholders may interpret the director's sale as a data point when evaluating their investment in Cryoport, potentially influencing their perception of insider confidence.
Key Dates
| Date | Description |
|---|---|
| 12/10/2025 | Date of transaction (sale of common stock by Ramkumar Mandalam) |
| 12/12/2025 | Date Form 4 was signed by the reporting person |
Keywords
Cryoport, CYRX, Insider Trading, Form 4, Stock Sale, Director Transaction, Ramkumar Mandalam, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.